PRESS RELEASE published on 03/12/2025 at 07:28, 1 year 5 months ago Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins Ipsen appoints Olivia Brown as EVP, Global Head of Neurotoxins, leading strategic growth in therapeutic and aesthetic neurotoxins market. Olivia brings 20 years of pharmaceutical and aesthetics leadership experience Innovation Ipsen Global Head Neurotoxins Olivia Brown
PRESS RELEASE published on 02/21/2025 at 15:42, 1 year 6 months ago Ipsen S.A. publie ses comptes consolidés 2024
PRESS RELEASE published on 02/21/2025 at 15:42, 1 year 6 months ago Ipsen S.A. publishes its 2024 consolidated financial statements
PRESS RELEASE published on 10/23/2024 at 07:00, 1 year 10 months ago Ipsen enregistre une forte dynamique commerciale au cours des neuf premiers mois de l'année 2024 et revoit à la hausse ses prévisions pour l'exercice en cours
BRIEF published on 09/23/2024 at 11:01, 1 year 11 months ago Franchissement de seuil par Parvus Asset Management dans IPSEN SA Euronext Paris Droits De Vote Franchissement De Seuil Ipsen SA Parvus Asset Management
BRIEF published on 09/23/2024 at 11:01, 1 year 11 months ago Parvus Asset Management crosses threshold in IPSEN SA Euronext Paris Voting Rights Threshold Crossing Ipsen SA Parvus Asset Management
PRESS RELEASE published on 09/23/2024 at 10:56, 1 year 11 months ago Franchissement de seuil Déclaration de franchissement de seuil par Parvus Asset Management Europe Limited pour le compte de clients et fonds détenant 7,80% du capital d'IPSEN SA Droits De Vote Franchissement De Seuil Ipsen SA Parvus Asset Management Cession Actions
BRIEF published on 09/16/2024 at 14:50, 1 year 11 months ago Des résultats prometteurs pour Cabometyx dans les tumeurs neuroendocrines avancées Phase III Ipsen Tumeurs Neuroendocrines ESMO 2024 Cabometyx
BRIEF published on 09/16/2024 at 14:50, 1 year 11 months ago Promising results for Cabometyx in advanced neuroendocrine tumors Phase III Ipsen Neuroendocrine Tumors ESMO 2024 Cabometyx
PRESS RELEASE published on 09/16/2024 at 14:45, 1 year 11 months ago Les résultats finaux de l’essai de Phase III CABINET corroborent les bénéfices en termes d’efficacité de Cabometyx® dans les tumeurs neuroendocrines avancées Les résultats finaux de l’essai de Phase III CABINET confirment l’efficacité de Cabometyx dans les tumeurs neuroendocrines avancées. Ipsen publie les données au congrès ESMO 2024 Essai Clinique Ipsen Tumeurs Neuroendocrines ESMO 2024 Cabometyx
Published on 09/02/2026 at 22:55, 3 hours 26 minutes ago Secure Blockchain Sells Delivery Trust(R) Business
Published on 09/02/2026 at 18:45, 7 hours 36 minutes ago Full Circle Lithium Rebrands as FCL-X Fire & Safety Inc. and Provides Corporate Update
Published on 09/02/2026 at 15:00, 11 hours 21 minutes ago Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Published on 09/02/2026 at 14:30, 11 hours 51 minutes ago Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 12 hours 21 minutes ago Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Published on 09/03/2026 at 01:05, 1 hour 16 minutes ago The Royal Mint Boldly Goes Where No Coin Has Gone Before With New Star Trek 50p Coins
Published on 09/02/2026 at 23:55, 2 hours 26 minutes ago Positive Preliminary Feasibility Study (PFS) outlines Vulcan’s second German project showcasing repeatable development growth strategy
Published on 09/02/2026 at 23:45, 2 hours 36 minutes ago EQS-Adhoc: Vulcan Energy Resources Limited: Positive Preliminary Feasibility Study (PFS) outlines Vulcan’s second German project showcasing repeatable development growth strategy
Published on 09/02/2026 at 19:50, 6 hours 31 minutes ago Cotecna Strengthens Food Testing Capabilities in India with Geo-Chem's New Food Safety Laboratory in Navi Mumbai, India
Published on 09/02/2026 at 19:00, 7 hours 21 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 09/02/2026 at 21:30, 4 hours 51 minutes ago Accor announces the success of OCEANEs due 2032 for a nominal amount of €380 million and the results of the partial repurchase of its outstanding OCEANEs due 2027
Published on 09/02/2026 at 21:30, 4 hours 51 minutes ago Accor annonce le succès d'OCEANEs à échéance 2032 pour un montant nominal de 380 millions d’euros et les résultats du rachat partiel de ses OCEANEs en circulation à échéance 2027
Published on 09/02/2026 at 19:03, 7 hours 18 minutes ago Communiqué au dépôt du projet de note d'information établi par Bourrelier Group